Navigation Links
Avanir Pharmaceuticals Reports Fiscal 2013 First Quarter Financial And Business Results
Date:2/7/2013

ALISO VIEJO, Calif., Feb. 7, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today reported financial results for the three months ended December 31, 2012.

(Logo: http://photos.prnewswire.com/prnh/20130207/LA55901LOGO)

Quarterly Financial Highlights

  • Total company net revenues increased to $16.5 million, representing growth of 22% versus the previous quarter
  • Gross and net NUEDEXTA® sales increased to $18.4 million and $14.9 million, respectively, representing growth of 19% and 20% versus the previous quarter
  • Cash, cash equivalents, and restricted investments of $59.3 million as of December 31, 2012.
  • "Avanir delivered another strong quarter of growth with record NUEDEXTA sales and prescriptions," said Keith A. Katkin , president and CEO of Avanir.  "In addition, the clinical team has successfully executed our plan to move our next generation asset, AVP-786, through the first stage of the phase I clinical study, with encouraging results. With demonstrated success in the AVP-786 study, we now have two promising assets in clinical development, each of which has broad potential in a number of CNS indications."

    Fiscal 2013 First Quarter Results

  • Total net revenues for the quarter ended December 31, 2012 were $16.5 million, compared with $7.2 million for the comparable quarter in fiscal 2012, representing 130% year-over-year growth. Total net revenues consist of NUEDEXTA revenue and royalty revenue from Abreva®.
  • Total operating expenses, excluding cost of sales and share-based compensation were $25.3 million in the first quarter of fiscal 2013, compared with $21.7 million in the comparable period in fiscal 2012.
  • Cash used in operations was $12.7
    '/>"/>

  • SOURCE Avanir Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Avanir Pharmaceuticals To Present at Three Conferences In May
    2. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Second Quarter Financial Results And Conference Call
    3. Avanir Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference
    4. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Third Quarter Financial Results And Conference Call
    5. Avanir Pharmaceuticals To Present At Two Investor Conferences In August
    6. Avanir Pharmaceuticals Announces Enrollment Of First Patient In Study Of AVP-923 For The Treatment Of Agitation In Patients With Alzheimers Disease
    7. Avanir Pharmaceuticals Announces Publication Of PBA Burden Of Illness Study
    8. Avanir Pharmaceuticals To Present At UBS Global Life Sciences Conference
    9. Avanir Pharmaceuticals Achieves Commercial Milestones & Provides Clinical Updates
    10. Avanir Pharmaceuticals To Present At 24th Annual Piper Jaffray Healthcare Conference
    11. Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2012 Fourth Quarter Results And Provides Clinical Study Update
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/27/2015)... , Feb. 27, 2015 WuXi PharmaTech (Cayman) ... technology platform company serving the pharmaceutical, biotechnology, and medical ... and the United States , ... designation from the U.S. FDA for ibalizumab (TMB355). The ... it is intended, alone or in combination with one ...
    (Date:2/27/2015)... TEL-AVIV , Israele, February 27, 2015 /PRNewswire/ ... continua nel suo sviluppo dell,innovativo sistema di monitoraggio ... il primo trial sull,uomo-   ... operante nello sviluppo di nuovo sistema per il ... congestizio (CHF), ha annunciato oggi di aver concluso ...
    (Date:2/27/2015)... , Feb. 27, 2015  Boston Scientific Corporation ... in the Barclays 2015 Annual Healthcare Conference on March ... Dan Brennan , executive vice president and ... president, Investor Relations, will participate in a 25-minute question ... analyst at approximately 1:05 p.m. ET. Following a 5-minute ...
    Breaking Medicine Technology:WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA 2Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2
    ... DALLAS, April 15, 2011 IntelliCentrics, Inc., owner and ... acquisition of Status Blue, LLC, a leading vendor compliance ... will unite the majority of the industry,s credentialing efforts ... IntelliCentrics a history of outstanding customer care and grounded ...
    ... Idaho and DANA POINT, Calif., April 15, 2011 ... and manufacturing nutritional supplements, today announced the establishment ... Resources (IHR), a renowned provider of medical information, ... wellness and health promotion, and integrative care. Health ...
    Cached Medicine Technology:IntelliCentrics, Inc. Acquires Hospital Vendor Credentialing Solution Status Blue, LLC 2IntelliCentrics, Inc. Acquires Hospital Vendor Credentialing Solution Status Blue, LLC 3Thorne Research and Integrative Health Resources Establish Joint Venture to Provide Full Range of Services in Practice Development, Patient and Clinician Education, and Access to Nutritional Supplements in Integrative Medicine 2Thorne Research and Integrative Health Resources Establish Joint Venture to Provide Full Range of Services in Practice Development, Patient and Clinician Education, and Access to Nutritional Supplements in Integrative Medicine 3Thorne Research and Integrative Health Resources Establish Joint Venture to Provide Full Range of Services in Practice Development, Patient and Clinician Education, and Access to Nutritional Supplements in Integrative Medicine 4
    (Date:2/27/2015)... FACE Skincare~Medical~Wellness, a multiaward-winning leader ... unique combination to take fifteen years off of ... a new treatment introduced that is the first ... to improve lines and wrinkles on the Décolleté. ... suffers from the stubborn vertical lines between the ...
    (Date:2/27/2015)... (PRWEB) February 27, 2015 Mediaplanet today ... “Blood Health,” a campaign that aims to bring blood ... health care conversation. The stories in this edition go ... world of clinical care, hard-hitting advocacy, research and technological ... , According the American Cancer Society, approximately every ...
    (Date:2/27/2015)... 27, 2015 Glidewell Laboratories, industry-leading ... launch of its CloudPoint™ family of ... production of monolithic zirconia crowns & bridges, CloudPoint ... providing the CAD/CAM-produced restorations that doctors demand. Installation ... which cases can be scanned, managed and produced. ...
    (Date:2/27/2015)... February 27, 2015 Healthpointe is ... suffered from injuries or diseases affecting the ... physicians are located throughout Southern California, and are ... to treat conditions related to the upper extremities. ... M. Ashley are board-certified and fully trained in ...
    (Date:2/27/2015)... CHICAGO, IL (PRWEB) February 27, 2015 ... start-up Output Medical to advance the development of ... commercialization. The new solution is being developed in ... that offer only 73% accuracy and error margins ... will automate error-free output measurement and provide trending ...
    Breaking Medicine News(10 mins):Health News:Face Skincare Announces New Combination Therapy 2Health News:Know Your Blood: Raising Awareness through Mediaplanet’s “Blood Health” Campaign 2Health News:Glidewell Laboratories Announces Release of CloudPoint™ FastScan™ and FastDesign™ 2Health News:Glidewell Laboratories Announces Release of CloudPoint™ FastScan™ and FastDesign™ 3Health News:Healthpointe is Now Performing Arthroscopic Surgery Techniques for Elbow, Hand and Wrist Injuries and Diseases, such as certain Ganglion Cysts 2Health News:Output Medical Joins Insight Accelerator Labs 2Health News:Output Medical Joins Insight Accelerator Labs 3
    ... Third ... ... Sacha Obaid, North Texas plastic and craniofacial surgeon , www.northtexasplasticsurgery.com announced ... at Cook Children,s Medical Center in Fort Worth. JT was born with an ...
    ... ... be focusing on the importance of family communications and promoting the value of open and ... ... should be top priority for parents this holiday season, according to Robert Moore, CEO of ...
    ... of after, clearly improves treatment of women with HER2+ breast ... a Mayo Clinic researcher who led what is regarded to ... Herceptin. Patients using Herceptin and chemotherapy at the ... risk of recurrence of cancer or death, compared with women ...
    ... , ... cosmetic dentist in Odessa, Texas , is participating in the popular Toys for Tots ... toys for the holidays. Donors at Dr. Rutherford’s practice are also entered into a drawing ... ...
    ... ... sales over the previous year. The increase is probably due to the giant tide of ... believes that LogoLoft.com is providing Americans with a valuable service during these hard economic times. ... Montgomery, Alabama (PRWEB) December ...
    ... DALLAS, Dec. 11 Baylor Health Care System,s website ... thirteenth annual Healthcare Internet Conference and silver at this ... awards program recognizes the best websites of healthcare organizations, ... and business improvement initiatives. More than 1,100 entries were ...
    Cached Medicine News:Health News:Surgeons Create Palate for Baby with Rare Facial Abnormality 2Health News:This Holiday Season Give Your Children the Gift that Saves Lives: Safer Sex 2Health News:Mayo Clinic researchers say breast cancer survival improves Herceptin used with chemotherapy 2Health News:Odessa Texas Cosmetic Dentist Sponsoring Marine Toys for Tots Program to Give Children in Need Free Toys for the Holidays 2Health News:Odessa Texas Cosmetic Dentist Sponsoring Marine Toys for Tots Program to Give Children in Need Free Toys for the Holidays 3Health News:LogoLoft.com Posts 64% Sales Increase Over Previous Year As More Americans Start Their Own Businesses 2Health News:BaylorHealth.com Wins National Healthcare Website Awards 2
    Console Horizontal Airflow Cabinet...
    ... chemical fumes, allowing safe indoor ... filters remove most organic contaminants. ... flow speed = 100 fpm ... air speed monitor, quick-release filter/blower ...
    ... fume hood ventilates and purifies ... release of exhaust. Bonded charcoal ... Configurations are available with vertical ... final HEPA filter, work bench ...
    ... polypropylene exhaust hoods are designed to rest ... draw a stream of air across the ... operator. Other sizes and types of hoods ... are available on special order in materials ...
    Medicine Products: